Christine is a Principal at Access Biotechnology, where she works on private and public investments. Prior to joining Access in 2019, Christine worked on therapeutics company creation at Apple Tree Partners. Before becoming an investor, Christine worked as an editor at several high-impact scientific journals, most recently as Chief Editor of Nature Medicine. She earned a PhD in Immunology at Harvard University and did her postdoctoral work in immunology at the University of Chicago.